Treatment of glucocorticoid induced hyperglycemia in patients with type 2 diabetes mellitus with omarigliptin at Okayama university hospital: an open label randomized controlled trial
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Omarigliptin (Primary)
- Indications Hyperglycaemia; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Good-MOMO study
- 08 Feb 2018 Status changed from recruiting to discontinued.
- 10 Aug 2017 Status changed from not yet recruiting to recruiting.
- 21 Apr 2017 New trial record